Lakosamid +pharma

Lacosamide, the active ingredient in Lakosamid +pharma, is a Anticonvulsant presented as an oral tablet for oral use. It treats partial‑onset seizures and is used in patients with epilepsy.

GNH USA supplies Lakosamid +pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an anticonvulsant indicated for seizure disorders and related neurological conditions.

- Partial‑onset seizures: reduces the frequency of focal seizures when used as adjunct therapy. - Epilepsy: helps control overall seizure activity in patients diagnosed with epilepsy. - Adjunctive therapy for refractory partial‑onset seizures: added when seizures are not adequately controlled by other antiepileptic drugs.

Lacosamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Nausea: upset stomach often accompanied by an urge to vomit. - Headache: mild to moderate pain in the head region.

Serious or Rare Side Effects: - Cardiac conduction abnormalities: such as PR‑interval prolongation, requiring ECG monitoring. - Suicidal thoughts or behavior: emergence of depressive symptoms or self‑harm ideation. - Severe skin reactions: including Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Aseptic meningitis: inflammation of the meninges without bacterial infection. - Hepatic injury: abnormal liver function tests indicating possible liver damage.

Before initiating therapy with Lacosamide, consider the following precautions. - Renal impairment: assess kidney function and adjust dose if necessary. - Hepatic impairment: monitor liver enzymes regularly during treatment. - Cardiac disease: evaluate ECG for conduction abnormalities in patients with known heart conditions. - Pregnancy: risk category unknown; use only when potential benefit justifies potential risk to the fetus. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Lacosamide can interact with several medications; awareness of the interaction level is essential.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase lacosamide plasma concentrations. - Strong CYP3A4 inducers (e.g., carbamazepine): may reduce lacosamide effectiveness. - Concurrent sodium‑channel blockers: may enhance central nervous system depression.

Moderate Interactions (Monitor Closely): - Oral contraceptives: lacosamide may reduce hormonal contraceptive efficacy. - Alcohol: combined use can increase dizziness and sedation. - Other antiepileptic drugs: dose adjustments may be required to maintain seizure control.